05-23-1200 Sigma-AldrichNeurotensin - CAS 39379-15-2 - Calbiochem
Potent hypothalamic peptide neurotransmitter.
More>> Potent hypothalamic peptide neurotransmitter. Less<<Synonyms: Pyr-LYENKPRRPYIL
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 39379-15-2 | C₇₈H₁₂₁N₂₁O₂₀ |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 05-23-1200-5MG |
|
Plastic ampoule | 5 mg |
|
— |
| References | |
|---|---|
| References | Kinkead, B., et al. 1999. Biol. Psychiatr. 46, 340. Tyler, B.M., et al. 1998. Brain Res. 792, 246. Tsuda, K., and Masuyuma, Y. 1993. Am. J. Hypertens. 6, 473. |
| Product Information | |
|---|---|
| CAS number | 39379-15-2 |
| ATP Competitive | N |
| Form | White to off-white lyophilized solid |
| Hill Formula | C₇₈H₁₂₁N₂₁O₂₀ |
| Chemical formula | C₇₈H₁₂₁N₂₁O₂₀ |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Sold on the basis of peptide content | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Modulator of noradrenergic activity |
| Purity | ≥97% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Peptide Content | Y |
| Peptide Sequence | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | QQ4482000 |
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 05-23-1200-5MG | 04055977206364 |
Documentation
Neurotensin - CAS 39379-15-2 - Calbiochem SDS
| Title |
|---|
Neurotensin - CAS 39379-15-2 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 05-23-1200 |
References
| Reference overview |
|---|
| Kinkead, B., et al. 1999. Biol. Psychiatr. 46, 340. Tyler, B.M., et al. 1998. Brain Res. 792, 246. Tsuda, K., and Masuyuma, Y. 1993. Am. J. Hypertens. 6, 473. |



